Genomic Health Q3 Revenues up 12 Percent | GenomeWeb

NEW YORK (GenomeWeb News) – Genomic Health reported after the close of the market Wednesday that its third-quarter revenues increased 12 percent year over year.

The Redwood City, Calif.-based molecular diagnostics firm said that revenues reached $58.6 million for the three months ended Sept. 30, up from $52.1 million, but short of the consensus Wall Street estimate of $59.9 million. Product revenues rose 13 percent year over year to $58.4 million from $51.7 million a year ago, while contract revenues dipped 25 percent to $277,000 from $397,000.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Cell this week: phosphoproteomic patterns in prostate cancer, effect of gene expression on fitness in yeast, and more.

Scripps Research Institute investigators peer back at the RNA world.

Being born premature shouldn't mean infants with high blood sugar levels don't undergo genetic testing for neonatal diabetes, a study in Pediatrics says.

In PNAS this week: chromosome instability in S. cerevisiae, structural differences and sequence divergence in rice, and more.